Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $12.11 million as of April 25, 2024. Its market cap has decreased by -27.91% in one year.

• Market Cap: 12.11M
• Enterprise Value: -608.48K
• 1-Year Change: -27.91%
• Ranking: #5187
• Category: Nano-Cap
• Stock Price: $1.87

Market Cap Chart

Since the IPO on December 23, 2020, Inhibikase Therapeutics's market cap has decreased from $100.46M to $12.11M, a decrease of -87.94%. That is a compound annual growth rate of -46.98%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	10.20M	14.61%
Apr 22, 2024	8.90M	-32.58%
Apr 19, 2024	13.20M	-2.94%
Apr 18, 2024	13.60M	-1.45%
Apr 17, 2024	13.80M	-
Apr 16, 2024	13.80M	-2.82%
Apr 15, 2024	14.20M	-
Apr 12, 2024	14.20M	-2.74%
Apr 11, 2024	14.60M	5.04%
Apr 10, 2024	13.90M	0.72%
Apr 9, 2024	13.80M	-3.50%
Apr 8, 2024	14.30M	0.70%
Apr 5, 2024	14.20M	-
Apr 4, 2024	14.20M	2.16%
Apr 3, 2024	13.90M	-
Apr 2, 2024	13.90M	-0.71%
Apr 1, 2024	14.00M	-
Mar 28, 2024	14.00M	-6.04%
Mar 27, 2024	14.90M	5.67%
Mar 26, 2024	14.10M	3.68%
Mar 25, 2024	13.60M	-1.45%
Mar 22, 2024	13.80M	1.47%
Mar 21, 2024	13.60M	7.09%
Mar 20, 2024	12.70M	6.72%
Mar 19, 2024	11.90M	-4.03%

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
GlucoTrack	12.82M
Purple Biotech	12.49M
RedHill Biopharma	12.47M
CareMax	12.40M
Imunon	12.22M
Biomerica	11.99M
Fresh2 Group	11.53M
Monopar Therapeutics	11.47M